| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/06/2011 | CN101264105B Lamb stomach extract vitamin B12 preparations composing prescription |
| 07/06/2011 | CN101264082B Compound for treating gastric injury |
| 07/06/2011 | CN101260091B Acrylamides compounds containing 1,2,3-thiadiazoles ring and having anti-hepatitis B virus activity |
| 07/06/2011 | CN101247792B Pharmaceutical compositions comprising a PH-dependent drug, a PH modifier and a retarding agent |
| 07/06/2011 | CN101243089B Halogenated pyrazolo [1,5-A]pyrimidines, processes, uses as GABA-A receptors ligand, compositions and intermediates |
| 07/06/2011 | CN101239091B Composition for preventing and controlling helicobacter pylori affection |
| 07/06/2011 | CN101208076B Controlled release formulations exhibiting an ascending rate of release |
| 07/06/2011 | CN101203517B 1- ( 2-amino-3- (substituted alkyl)-3h-benzimidazoiylmethyl) -3-subtituted-1,3-dihydro-benzoimidazol-2-ones with activity on respiratory syncytial virus |
| 07/06/2011 | CN101198614B Thienopyrimidine derivative |
| 07/06/2011 | CN101181263B Treatment of respiratory diseases |
| 07/06/2011 | CN101152186B Progesterone injection and method for preparing the same |
| 07/06/2011 | CN101151264B Crystalline form of a quinolinone-carboxamide compound |
| 07/06/2011 | CN101151262B Substituted piperidines |
| 07/06/2011 | CN101142191B Process for the preparation of 10,11-dihydro-10-hydroxy-5h-dibenz[b,f]azepine-5-carboxamide |
| 07/06/2011 | CN101141961B Stable particular pharmaceutical composition of solifenacin or salt thereof |
| 07/06/2011 | CN101119986B Optically active tetrahydronaphthalene derivative |
| 07/06/2011 | CN101102777B Drug and food or drink for improving pancreatic functions |
| 07/06/2011 | CN101068555B Anti-adhesion spraying |
| 07/06/2011 | CN101052397B 2-sulfanyl-benzimidazol-1-yl-acetic acid derivatives as crth2 antagonists |
| 07/06/2011 | CN101048408B Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 07/06/2011 | CN101014572B Carbamoylpyridone derivative having HIV integrase inhibitory activity |
| 07/06/2011 | CN101007062B Traditional Chinese medicine composition capable of resisting infection |
| 07/05/2011 | US7973170 N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 07/05/2011 | US7973169 including cystic fibrosis transmembrane conductance regulator ("CFTR"), such as N-(4,5-Diphenyl-thiazol-2-yl)-benzamide, used for treating genetic disorders; respiratory system disorders |
| 07/05/2011 | US7973163 Fused quinoline derivative and use thereof |
| 07/05/2011 | US7973162 Modulators of muscarinic receptors |
| 07/05/2011 | US7973160 Nitrogen-containing aromatic derivatives |
| 07/05/2011 | US7973159 Non-basic melanin concentrating hormone receptor-1 antagonists |
| 07/05/2011 | US7973145 Sulfonated sugar compounds, pharmaceutical compositions which contain the same, and methods of treating tumors with the same |
| 07/05/2011 | US7973143 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 07/05/2011 | US7973084 High permeability through plasma membrane, nuclear membrane and blood-brain barrier; for delivering doxorubicin and paclitaxel to target cells; gene therapy |
| 07/05/2011 | US7973083 Pesticidally active compounds |
| 07/05/2011 | US7973082 Substituted aryloxy alkylamines and their use as monoamine neurotransmitter re-uptake inhibitors |
| 07/05/2011 | US7973080 Method for inhibiting the growth of antibiotic resistant of bacteria by using pentane-1,5-diol |
| 07/05/2011 | US7973079 Methods and compounds for treating retinol-related diseases |
| 07/05/2011 | US7973077 Amino acid based compositions for the treatment of pathological conditions distinguised by insufficient mitochondrial function |
| 07/05/2011 | US7973076 Stilbene derivative and a platinum coordination compound composition highly efficacious and highly safe; Diammine(1,1-cyclobutanedicarboxylato)platinum (II) |
| 07/05/2011 | US7973075 Kainate receptor-selective epimeric analogs of dysiherbaine |
| 07/05/2011 | US7973074 π-conjugated mono-, oligo- and polymeric compounds, and photovoltaic cells comprising them |
| 07/05/2011 | US7973073 Antidiabetic agent for control of diabetic hyperglycemia and diabetic complications |
| 07/05/2011 | US7973072 Pain, eating disorders, neurodegenerative disorders, memory impairment; attention deficit syndrome, opioid tolerance, drug addiction; (4-oxothiochroman-3,3-diyl)bis(methylene)bis(3-(trifluoromethyl)benzoate for example |
| 07/05/2011 | US7973071 Substituted gamma lactams as therapeutic agents |
| 07/05/2011 | US7973070 Monatin hydrate crystals |
| 07/05/2011 | US7973069 Methods for treating hepatitis C |
| 07/05/2011 | US7973068 Comprises alpha-adrenergic receptor agonist such as clonidine; side effect inhibition |
| 07/05/2011 | US7973067 Heterocyclic aspartyl protease inhibitors |
| 07/05/2011 | US7973066 Pyrrolo[1,2-A]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agents |
| 07/05/2011 | US7973065 Antimicrobial compounds |
| 07/05/2011 | US7973064 Administering to a mammal therapeutically effective amount of opiate analgesic and endothelin antagonist for therapy and prophylaxis of pain |
| 07/05/2011 | US7973063 Methods for activating PPAR gamma-type receptors |
| 07/05/2011 | US7973062 Androgen receptor-ablative agents |
| 07/05/2011 | US7973061 Anaplastic lymphoma kinase modulators and methods of use |
| 07/05/2011 | US7973060 Fab I inhibitor and process for preparing same |
| 07/05/2011 | US7973059 Potassium channel inhibitors |
| 07/05/2011 | US7973058 Transdermal methods and systems for the delivery of anti-migraine compounds |
| 07/05/2011 | US7973057 Thalidomide analogs |
| 07/05/2011 | US7973056 Triazole derivative or salt thereof |
| 07/05/2011 | US7973055 Biphenyl-2-ylcarbamic acid 1-[2-({3-[2-(4-hydroxybenzylamino)ethylcarbamoyl]benzoyl}methylamino)ethyl]piperidin-4-yl ester; drug delivery; pulmonary disorders |
| 07/05/2011 | US7973054 Use of glucosidase inhibitors for therapy of mucovisidosis |
| 07/05/2011 | US7973053 Nerve cell death inhibitor |
| 07/05/2011 | US7973052 Compounds for the treatment of metabolic disorders |
| 07/05/2011 | US7973051 Aminothiazoles as FBPase inhibitors for diabetes |
| 07/05/2011 | US7973050 5-[3-((R)(-)-5,7-Dibromo-1,2,3,4-tetrahydro-naphthalen-1-ylamino)-propylamino]-4H-thieno[3,2-b]pyridine-7-one; optically active; new target antibiotic, inhibitor of bacterial methionyl tRNA synthetase; antibiotic resistance; Clostridium difficile infection; mostly in immunodeficient, elderly |
| 07/05/2011 | US7973049 Morphinan compounds |
| 07/05/2011 | US7973048 Pharmaceutical composition |
| 07/05/2011 | US7973047 Beta-Secretase modulators and methods of use |
| 07/05/2011 | US7973046 Use of allopurinol for the treatment of palmar plantar erythrodysesthesia |
| 07/05/2011 | US7973044 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/05/2011 | US7973043 Combination therapy for depression, prevention of suicide, and various medical and psychiatric conditions |
| 07/05/2011 | US7973042 Derivatives of alkylpiperazine- and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as fatty acid amido hydrolase enzyme inhibitors |
| 07/05/2011 | US7973041 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 07/05/2011 | US7973040 Macrocyclic quinoxaline compounds as HCV NS3 protease inhibitors |
| 07/05/2011 | US7973039 3-(1,3-benzodioxol-5-yl)-1-({[4-(4-fluorophenyl)-1-piperazinyl]sulfonyl}methyl)-2-propynyl(hydroxy)formamide; analgesics, anticarcinogenic agents, antiarthritic agents; matrix metalloproteinase inhhibitors |
| 07/05/2011 | US7973038 Modulators of ATP-binding cassette transporters |
| 07/05/2011 | US7973037 N1-(cyanomethyl)-N2-(2,2,2-trifluoro-1-phenylethyl)-L-leucinamide; antiarthritic agent; osteoporosis and other bone loss disorders |
| 07/05/2011 | US7973036 2-methyl-5-imino-benzo[D][1 ,3]oxazin[5-B]pyrazole compound, preparation and use thereof |
| 07/05/2011 | US7973035 Inhibitors of C-FMS kinase |
| 07/05/2011 | US7973034 Amide, aryl sulfonamide, aryl urea, and α,β-diketone derived carboxylesterase inhibitors, and their methods of use |
| 07/05/2011 | US7973033 Multi-cyclic cinnamide derivatives |
| 07/05/2011 | US7973032 Staurosporine derivatives for use in alveolar rhabdomyosarcoma |
| 07/05/2011 | US7973031 Leukemia therapy ;myelodyspastic syndrome |
| 07/05/2011 | US7973030 Benzothiazepine and benzothiepine compounds |
| 07/05/2011 | US7973029 Inhaled aztreonam lysine for the treatment of deficits in health-related quality-of-life in lung diseases |
| 07/05/2011 | US7973027 Compound with antimalarial activity and antimalarial drug containing the same as active ingredient |
| 07/05/2011 | US7973026 Thienopyrroles as antiviral agents |
| 07/05/2011 | US7973025 Compositions and methods of treating retinal disease |
| 07/05/2011 | US7973024 24-sulfoximine vitamin D3 compounds |
| 07/05/2011 | US7973023 Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders |
| 07/05/2011 | US7973022 Fluoroquinolone carboxylic acid salt compositions |
| 07/05/2011 | US7973021 Immunomodulating agent in gut |
| 07/05/2011 | US7973020 Compositions and methods for inhibiting expression of a gene from the ebola virus |
| 07/05/2011 | US7973017 For treatment of endocrine-regulated tumors, for example, breast, prostate, ovarian and colon cancers |
| 07/05/2011 | US7973015 Induction of exon skipping in eukaryotic cells |
| 07/05/2011 | US7973014 Angina pectoris, myocardial ischemia, hemorrhagic shock, heart failure, and arrhythmia; ginsenoside with protopanoxadiol as aglucone (ginsenoside Rg3) and the ginsenoside with protopanoxatriol as aglucone (ginsenoside Rg2 and ginsenoside Rh1) |
| 07/05/2011 | US7973013 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment |
| 07/05/2011 | US7973012 C-phenyl glycitol compound |
| 07/05/2011 | US7973006 Antibacterial agent based on fatty acid esters of hydroxy carboxylic acid acids |
| 07/05/2011 | US7973005 Alpha-1 antitrypsin for treating exacerbation episodes of pulmonary diseases |
| 07/05/2011 | US7972816 Contains only promoter and transcription sequence regions which minimizes immunogenicity because it does not contain extra sequences; resistant to digestion and relatively stable in serum and cells |
| 07/05/2011 | US7972811 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries |